Pancreatic Cancer
Clinical research in unresectable locally advanced pancreatic cancer with a focus on treatment delivery in a difficult-to-access tumour setting.
- Locally advanced pancreatic malignancy
- Unresectable disease
- Peri-tumoral therapy delivery
The sponsor’s activity is centred on interventions relevant to pancreatic oncology, particularly approaches intended to support drug administration in patients whose disease cannot be surgically removed.
Oncology Drug Delivery
Research interest in targeted local delivery for cancer treatment, with emphasis on placing therapeutic agents close to the tumour site.
- Intratumoral administration
- Peri/intratumoral delivery
- Regional infusion techniques
This area reflects a therapeutic focus on improving access to malignant tissue through specialised infusion catheter-based delivery methods.
Vascular Access and Infusion Technology
Clinical investigation of a device-based approach for administering therapeutic solutions into the peri/extravascular space of the peripheral vasculature.
- Infusion catheter systems
- Peripheral vasculature
- Extravascular administration
The sponsor is engaged in device-oriented research that supports precise placement of treatment in relation to vascular structures.
Therapeutic Supportive Procedures
Interest in procedural methods that enable local administration of gemcitabine within a specialised oncology setting.
- Gemcitabine delivery
- Local treatment administration
- Specialised interventional oncology
Research activity is aligned with clinical use of delivery technologies designed for patients requiring focused treatment to the tumour region.
